Article Details

Adlai Nortye Biopharma Raises $53M in Series B Financing

Retrieved on: 2018-07-04 22:48:45

Tags for this article:

Click the tags to see associated articles and topics

Adlai Nortye Biopharma Raises $53M in Series B Financing. View article details on hiswai:

Excerpt

<div>Backers included YuanMing Capital, <b>Matrix Partners</b> China, DT Capital Partners, and Yahui Precision Medicine Fund. Led by Carsten Lu, CEO, Adlai ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up